Athira Pharma Inc (ATHA) — Long-term Investment Intensity
Athira Pharma Inc (ATHA) has a Long-term Investment Intensity of 4.9% as of June 2023. Long-term investments of $10.22 Million represent 4.9% of total assets of $208.05 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Athira Pharma Inc's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Athira Pharma Inc Long-term Investment Intensity (2020–2022)
This chart shows how Athira Pharma Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the intensity stands at 4.9%, reflecting long-term investments of $10.22 Million against total assets of $208.05 Million USD. For the complete balance sheet picture, see ATHA asset base.
Annual Long-term Investment Intensity for Athira Pharma Inc (2020–2022)
The table below presents the year-by-year Long-term Investment Intensity for Athira Pharma Inc from 2020 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Athira Pharma Inc debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 17.4% | $44.83 Million | $258.15 Million | ▼ -2.5 pp |
| 2021 | 19.9% | $65.94 Million | $332.01 Million | ▼ -10.0 pp |
| 2020 | 29.9% | $83.51 Million | $279.56 Million | — |